我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的隐私政策。
相关临床试验
2229
2156 进行中
药物批准
0
批准总数
监管机构
监管机构数
成立时间
N/A
招募中
61
2.7%
进行中（未招募）
2156
96.7%
已完成
12
0.5%
暂无批准数据
- Bristol-Myers Squibb, founded in 1858, has evolved from a small Brooklyn pharmaceutical company to a global healthcare leader with approximately 28,000 employees and focus on six core therapeutic areas. - The company's landmark merger in 1989 created a pharmaceutical powerhouse with combined profits of $1.3 billion, leading to over 60 product lines generating $50+ million in annual sales by 1995. - BMS maintains a robust pipeline with 40 compounds in exploratory development and 6 in late-stage development, despite facing patent expiration challenges for key drugs like Plavix and Avapro.
